Comparison

RxCourse vs OmimO

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

RxCourse

This platform offers online social learning for pharmacists to prepare for board exams and advance in the pharmaceutical industry. It allows users to engage with courses anytime, anywhere, and connect with peers by making and joining groups.

Highlights
  • Pharmacy board exam preparation
  • Drug safety and pharmacovigilance courses
  • Social learning features
  • Group creation and joining
  • Mobile access to courses
Features
Read full description

RxCourse platform is an online social learning platform for pharmacists; it enables you to prepare for the pharmacy examination board of Canada PEBC exams and helps you gain a foothold in the pharmaceutical industry like Drug safety and pharmacovigilance along with other healthcare courses. This app will help you engage in your courses more and finish them faster, as you will be able to take your courses with you anywhere and anytime. You will be able to make friends, join groups and make your groups. It's one prescription that every international pharmacist and healthcare professional needs.

About

OmimO

This app helps users combat the forgetting curve with daily revision questions and personalized review schedules. Users rate their recall of information, and the app adapts to prioritize challenging content for better memory retention.

Highlights
  • Daily revision questions
  • Personalized review scheduling
  • Memory recall rating system
  • 141 clinical and practical topics
  • Customizable study levels
  • Flexible study session options
Features
Read full description

OmimO helps you pass the Canadian PEBC pharmacy licensing exam — and actually remember what you study. Built on spaced repetition, OmimO brings each concept back right before you'd forget it, so it moves into long‑term memory instead of leaking away after a cram session. WHY OMIMO • Calibrated exam‑readiness — an honest read on how prepared you are, weighted by the PEBC blueprint • Explain with OmimO AI — instant, grounded reasoning for why an answer is right • Daily Memory Workout — a plan tuned to your competencies, level, and timeline • Active recall over re‑reading — the method proven to stick • Filter new vs. review, focus your weakest areas, and rescue the cards you keep missing • Stats, streaks, and progress that keep you moving FREE TO START 10 new Snippets and 1 AI explanation a day, free. Go Pro for unlimited Snippets and AI explanations — with a 7‑day free trial. Whether you're an IPG preparing for the Evaluating Exam, sitting Qualifying Exam Part I, or a practicing pharmacist staying sharp, OmimO maps out exactly what to study, and when. Subscription Details: Subscription Fee: $14.99 CAD per month. Auto-Renewal: The subscription automatically renews each month unless cancelled by the user. Access and Features: Subscribers have continuous access to all OmimO content for the duration of their subscription. However, it’s important to note that the content is not downloadable and cannot be accessed once the subscription ends. Diverse Content Library: OmimO’s library encompasses 141 topics, including a wide array of clinical topics such as Diabetes, Cardiovascular Diseases, Depression, ADHD, etc., alongside practical skills like counseling, billing and adjudication, and other foundational skills. This rich variety ensures that OmimO caters to the broad spectrum of needs for Canadian pharmacists and candidates preparing for the PEBC exams. Adaptability to Study Needs: Users can tailor their study experience by choosing their preferred study level—PEBC Evaluating Exam, PEBC MCQ Exam, PEBC OSCE Exam, or Licensed Pharmacist. The flexibility to switch between levels as needed allows for a customized revision path that aligns with the user's progression and goals. Flexible Study Sessions: Subscribers can customize their daily study sessions by choosing the number of new information cards and review cards. Interactive Learning: Users rate each piece of information based on difficulty (easy, medium, or hard), using color-coded buttons (green, yellow, or red). Personalized Revision Schedule: The app’s algorithm calculates the optimal time to revisit information based on user ratings, enhancing memory retention. This comprehensive package not only offers an invaluable resource for ongoing education but also aligns with the convenience and affordability of today’s digital subscription services, making it an essential tool for professionals seeking to maintain and enhance their knowledge in the field. Purpose and Scope: OmimO is designed as a comprehensive revision tool to supplement, not replace, other study sources. While it provides extensive coverage of relevant topics, it is not intended to be the sole resource for exam preparation or professional development. Independence from PEBC: OmimO is not affiliated with the Pharmacy Examining Board of Canada (PEBC). “PEBC” and “Pharmacy Examining Board of Canada” are trademarks of the Pharmacy Examining Board of Canada, and OmimO operates independently as a revision and educational tool. ----- Our Privacy Policy: https://www.omimo.ca/privacy Terms of service: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/ Learn More about how we create our content: https://www.omimo.ca/content Get to know how to use OmimO: https://www.omimo.ca/demo

Screenshots

RxCourse4 screens
OmimO4 screens

Verdict

The call

The clearest difference is rating: RxCourse at 5.0 against OmimO's 4.0. RxCourse also leads on monetization model (free with in-app purchases vs subscription). On price, ratings volume, update cadence and ads there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. RxCourse sells 5 one-off in-app purchases and OmimO sells 1 in-app purchase, starting at $9.99 per month. Whichever you choose, the download price is not the number that matters.

ReceptionRating · Positive reviews · Number of ratings

RxCourse holds the better App Store score, 5.0 against 4.0. Both are backed by a comparable volume of ratings — 1 and 1 respectively.

UpkeepUpdate frequency

RxCourse ships an update every 3 weeks, OmimO every 2 weeks. The most recent releases landed on October 14, 2026 and September 22, 2026 respectively.

Scorecard2 real differences · 7 level
RxCourse versus OmimO: the parameters behind the verdict, then further details
ParameterRxCourseOmimO
PriceFreeFree
Rating5.0 (1 ratings) — better4.0 (1 ratings)
Number of ratings11
Update frequencyEvery 3 weeksEvery 2 weeks — better
AdsNoNo
In-app purchasesYesYes
MonetizationFree with in-app purchases — betterSubscription
DevicesiPhone, iPad, iPod — betteriPhone, iPad
Requires iOS15.515.1 — better
Further details — not scored
Size95 MB25 MB
Age rating17+17+
DeveloperRxCourse Institute Inc.OMIMO Pharma Inc

Customer experience

RxCourse

All ratings1 ratings
Positive100.0%
Neutral0.0%
Negative0.0%

OmimO

All ratings1 ratings
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

5 purchases

RxCourse

One-time5
  • M0 PV Introduction and Basics$399.99
  • M1Drug Safety Regulation & GVP$449.99
  • M2 PV & Drug Safety Operations$499.99
Show 2 more
  • M3 Safety Medical Writing & QA$549.99
  • PEBC Evaluating Exam Prep.$699.99
1 purchases

OmimO

Subscriptions1
  • OmimO Monthly7 Days trial$9.991 Month

Questions

Is RxCourse free?
RxCourse is free to download, with in-app purchases available.
Is OmimO free?
OmimO is free to download, with in-app purchases available.
Which has better reviews, RxCourse or OmimO?
RxCourse is rated higher. RxCourse averages 5.0 out of 5 from 1 ratings, while OmimO averages 4.0 from 1 ratings.
Do RxCourse or OmimO have ads?
Neither RxCourse nor OmimO shows ads.
Which is updated more often, RxCourse or OmimO?
RxCourse ships an update every 3 weeks, and OmimO every 2 weeks. Most recently, RxCourse was updated on October 14, 2026 and OmimO on September 22, 2026.

Other comparisons